Cargando…
Cytokine Targeted Therapy for Dupuytren's Disease
Autor principal: | Satish, Latha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116413/ https://www.ncbi.nlm.nih.gov/pubmed/30030135 http://dx.doi.org/10.1016/j.ebiom.2018.07.016 |
Ejemplares similares
-
Anti-fibrotic action of pirfenidone in Dupuytren’s disease-derived fibroblasts
por: Zhou, Chaoming, et al.
Publicado: (2016) -
Developing an animal model of Dupuytren’s disease by orthotopic transplantation of human fibroblasts into athymic rat
por: Satish, Latha, et al.
Publicado: (2015) -
Dupuytren’s disease and the risk of malignant neoplasms
por: Żyluk, Andrzej, et al.
Publicado: (2014) -
Investigating the effects of Pirfenidone on TGF-β1 stimulated non-SMAD signaling pathways in Dupuytren’s disease -derived fibroblasts
por: Zhou, Chaoming, et al.
Publicado: (2019) -
Extracorporeal Shock Wave Therapy in Dupuytren’s Disease
por: Aykut, Serkan, et al.
Publicado: (2018)